SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 93 filers reported holding SEELOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,792 | -90.0% | 303,215 | -35.0% | 0.00% | – |
| Q2 2023 | $557,748 | +129008.3% | 466,735 | -25.3% | 0.00% | – |
| Q1 2023 | $432 | -15.0% | 624,862 | -16.5% | 0.00% | – |
| Q4 2022 | $508 | -99.9% | 747,985 | -18.6% | 0.00% | -100.0% |
| Q3 2022 | $947,000 | -12.3% | 919,068 | -42.1% | 0.00% | 0.0% |
| Q2 2022 | $1,080,000 | +496.7% | 1,586,989 | +634.7% | 0.00% | – |
| Q1 2022 | $181,000 | -85.4% | 216,005 | -71.5% | 0.00% | -100.0% |
| Q4 2021 | $1,236,000 | -62.0% | 758,295 | -43.8% | 0.00% | -50.0% |
| Q3 2021 | $3,254,000 | -34.4% | 1,350,283 | -28.1% | 0.00% | -33.3% |
| Q2 2021 | $4,959,000 | +54.2% | 1,878,474 | +191.4% | 0.00% | +50.0% |
| Q1 2021 | $3,216,000 | +1409.9% | 644,543 | +918.3% | 0.00% | – |
| Q1 2019 | $213,000 | – | 63,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENDELL JEFFREY L | 4,933,024 | $4,133,000 | 0.30% |
| ACUTA CAPITAL PARTNERS, LLC | 295,896 | $248,000 | 0.12% |
| Connacht Asset Management LP | 231,551 | $194,000 | 0.10% |
| Uniplan Investment Counsel, Inc. | 1,564,605 | $1,310,000 | 0.08% |
| AdvisorShares Investments LLC | 358,796 | $301,000 | 0.05% |
| 1492 Capital Management LLC | 99,819 | $84,000 | 0.04% |
| Woodline Partners LP | 2,803,230 | $2,349,000 | 0.04% |
| Ikarian Capital, LLC | 257,883 | $215,000 | 0.03% |
| Sovereign Financial Group, Inc. | 75,000 | $63,000 | 0.02% |
| Aquatic Capital Management LLC | 6,400 | $5,000 | 0.01% |